Int. J. Epidemiol. Advance Access published May 11, 2009
Published by Oxford University Press on behalf of the International Epidemiological Association
International Journal of Epidemiology 2009;1–4
ß The Author 2009; all rights reserved.
Commentary: The appearance of new medicalcosmologies and the re-appearance of sick andhealthy men and women: a comment on themerits of social theorizing
Published 32 years ago in the British Sociological
Judging by the guidelines and resource allocation of
Association’s journal Sociology, Nick Jewson’s paper
some of the main funding councils who support
‘The Disappearance of the Sick-Man from Medical
health, medically related and even social research in
Cosmology, 1770–1870’1 is something of a classic.
the UK, there seems to be an imperative to support
A search using the Thomson ISI Web of Knowledge
applied and policy relevant empirical research that
Service reveals that, within this database, the article
can generate clear outcomes. There is no doubt that
has some 133 citations and rate of citations have
such research can make an important contribution
remained consistent over time. Furthermore, the
to patient well being, but in a world steeped in the
impact is not limited to sociology; the top six subject
evidence-based culture this could mean that larger
areas that return the highest citation scores are ‘his-
and possibly more important questions and insights
tory and philosophy of science’ (29.3%); ‘social
may be overlooked. Indeed, Jewson’s historical mate-
sciences, biomedical’ (23.3%); ‘public, environmental
rialist analytic strategy of ‘modelling’ different histor-
and occupational health’ (21.1%); ‘sociology’ (20.3%);
ical periods may well be considered to be to abstruse
‘health care sciences and services’ (12.8%); and ‘med-
by many working in public health, epidemiology or
icine, general and internal’ (6.0%).
It is intriguing that this conceptual paper should
But Jewson’s modelling of historical forms of med-
have such an enduring and broad significance. But
ical knowledge and practices are both descriptive and
herein lies its merit; as the sociologist Bryan Turner
explanatory. To be sure the broad brush approach is
notes: ‘Ultimately sociology can better serve the prac-
invariably at the cost of historical detail. The medical
tical problems and needs of patients by formulating
cosmologies are what the sociologist Weber would
sociological rather than medical questions.’2 This
call ‘ideal types’; idealized versions or abstractions
statement reflects Strauss’s well-known distinction
that aim to capture the quintessence of social realities. Arguably these abstractions enable us to see beyond
between ‘sociology in medicine’ and ‘sociology of
the messy veracity of day-to-day life; to use a well-
medicine’.3 The former refers to research agendas
worn metaphor they allow us to ‘see the wood for the
that are professionally and institutionally driven,
trees’. Such distancing can contribute at a societal
whereas the latter implies a more critical approach,
level to an appreciation of why decisions are made,
wherein the philosophical and epistemological under-
why certain forms of knowledge or practices are prior-
pinnings of medical knowledge and medical practice
itized and how social change comes about.
are open to scrutiny. Jewson’s analysis certainly scru-
And, in fact, Jewson’s paper reveals a correspon-
tinises the content of medical knowledge and reveals
dence between broader socio-material changes, tech-
how it is contingent upon socio-economic relations
nological innovations and a privileging of particular
between the patrons and producers. At a time when
forms of knowledge. The value of this revelation is
health and social researchers are increasingly encour-
the confirmation that medical knowledge, practices
aged to undertake empirically-based and policy-
and technologies are socially contingent. They are
orientated research it is useful to reflect on the
mediated by ‘the social’, be that social interests, cul-tural preferences, economics or social hierarchies. Salutatory reflections today in the context of health
Department of Sociology, University of York, Heslington, York
and medical care where we see claims and counter-
claims relating the merits and demerits of, on the one
hand, highly technical and hitherto unprecedently
module I teach on the sociology of health and illness
expensive, therapeutic interventions and, on the
earlier this year, one student wondered if in the con-
other hand, a diversity of complementary and alter-
temporary context doctors working in general practice
might find it difficult sometimes to implement the
The central argument of the paper reveals how three
findings of research. Treatments of ‘proven’ benefit
medical cosmologies—‘bedside medicine’, ‘hospital
might be at odds with the biography of the patient
medicine’ and ‘laboratory medicine’—were differen-
that becomes evident at the bedside. Spot on. Such
tially privileged in distinct historical periods and
tensions are of course increasingly apparent in the
were conditional upon the sources of patronage; cru-
context of the informatization of medicine wherein
dely who influenced the mode of production of med-
guidelines derived from ‘gold standard’ RCTs may be
ical knowledge. This strand of the argument is
at odds with clinicians preferred approach to disease
articulated more fully in an earlier (though less
management for given patients in the light of their
cited) paper ‘Medical Knowledge and the Patronage
personalized needs.6 As Stephen Harrison explains
System in 18th Century England’.4 In the era of bed-
there are epistemological (cosmological perhaps?) dif-
side medicine the doctor had a close interpersonal rela-
tionship with his client who, being the doctor’s
which, we might add, mirror those between the pro-
patron, exerted considerable influence over medical
tagonists and the sceptics in Paris centuries ago. As
knowledge, which in turn tended to be heterogeneous
we know the proponents of EBM maintain that ‘evi-
and biographical not least because doctors developed
dence’ is based on an authoritative probabilistic
their own styles and theories to suit their paying
model of science in contrast with the ‘traditional
model’, wherein clinicians seek to understand the
The historical importance of the Parisian hospital
natural history of the disease by observing how ‘dis-
schools in post-revolutionary France was critical to
ease processes develop over time and impact upon
the formation of the next cosmology. The prime site
normal physiological processes’.7 Today, however,
of investigation shifted from the patients’ bedside to
doctors’ recourse to the ‘clinical gaze’8 forged in the
the hospital ward. Thus the ‘sick man’ was displaced
era of hospital medicine is being marginalized; clini-
by the ‘sick body’—the latter was an object of inves-
cians are encouraged to heed the advice based on ‘the
tigation and what s/he had to say was of little con-
publication of meta-analyses of large numbers of
sequence because the goal of the Parisian clinician
cases’.6 Consequently, commentators are expressing
was to impress his colleagues with his diagnostic
concerns that experiential and intuitive knowledge—
skills. Prognosis was of secondary interest and thera-
the ‘art of medicine’—may be in jeopardy.9–11
peutic interventions positively shunned. The gold
In Jewson’s terms, what we see here is a shift in the
standard of medicine was to investigate the inner
influence of the control over the production of med-
reaches of the anatomy unsullied by the patients’
ical knowledge—no longer purely in the hands of the
interpretation of their symptoms in order to identify
clinician (as in hospital medicine) or the scientist (as
accurately any pathological abnormality.
in laboratory medicine) but in a new hybrid fashioned
Tensions, however, were manifest; protagonists of
through the combined expertize of epidemiologists
the physical diagnosis advocated the cultivation of
and information scientists. These specialists are sup-
an objective, proven body of knowledge that could
ported by the state and, more significantly, in some
be applied to all patients rather than individuals
settings deployed by well-resourced biotechnology
with all their idiosyncrasies. Sceptics of these new
and pharmaceutical industries—who are keen to gen-
schools, most notably those working predominantly
erate convincing knowledge about the effectiveness or
in private practice, remained keen to offer their
cost-effectiveness of interventions.
patients prognoses and therapies. Thus the socio-
The medicalization thesis that dominated sociological
economic relations between practitioner and patient
debates in the 1970s drew on Jewson’s account to
were crucial; working in the hospital the patients
explain the rise and dominance of the biomedical
of the protagonists were poor, conditions often
model in Western medicine. In the 1970s, sociologists’
wretched, and in fact, in such circumstances any ther-
criticized medicine for medicalizing aspects of everyday
apeutic interventions would have limited chance of
life from birth to death. However, it is now suggested
success. However, in post-revolutionary France it
that the medical practitioners are merely ‘bit players’,
was state support that transformed this pivotal insti-
and it is the globalized and hugely powerful biotech-
tution; as the historian Ackerknecht (who was closely
nology and pharmaceutical enterprises that are more
read by Jewson) put it: ‘The Paris hospital of our
effective in creating and sustaining knowledge about
period was, in its conception and organisation, no
the presence of disease and need for treatments.12 A
longer a medieval receptacle of all miseries. It had
well-known example is David Healey’s work on the
eventually become a medical institution and thus
ways in which the psycho-pharmaceutical industry
served as the cradle of a new medicine.’5
effectively markets and thereby constructs mental
Sounds familiar? Well when discussing this paper
health disorders.13 As Nikolas Rose has put it today:
with students at the start of an undergraduate
‘Depression: not so much fluoxetine hydrochloride as
A COMMENT ON THE MERITS OF SOCIAL THEORIZING
Prozac. Generalized Anxiety Disorder: not so much par-
now takes the form of an e-scape in the sense that
oxetine as Paxil. ADHD: not methylphenidate or
the spaces, sites and locations of the production of
medical knowledge are now more diffuse and are
Adderall. Premenstrual dysphoric disorder: not so
invariably mediated by means of digital technologies.
much fluoxetine hydrochloride (again) but Sarafem.
We see a greater variation of sick men and women
And some more names: Prozac and Sarafem: Eli
today (Marxist sociologists made little mention of
women in the 1970s!). These include the sick
(CibaGeigy). Adderall: Shire-Richmond’.14
person, the passive patient, the expert patient, the
Jewson was neither the first nor the last analyst to
inert body, the responsible and the culpable indivi-
identify a series of medical paradigms. Indeed, as
dual and the health care consumer and, more recently
noted above he is indebted to Ackerknecht for both
the ‘prosumer’ (those who both produce and consume
historical detail and the naming of the historical per-
knowledge and information—perhaps most saliently
spectives. Ackerknecht used similar labels such as
within web 2.0 applications). New medical cosmolo-
‘Library Medicine’ (wherein a classical education
gies emerge whilst others recede, but each leaves an
was a pre-requisite of medical work), ‘Bedside
enduring residue. The sick men who disappeared from
Medicine’ and ‘Hospital Medicine’. David Armstrong,
view in the 19th century have reappeared in a multi-
adopting a Foucauldian orientation, suggests a further
plicity of guises. Patients, health conscious (or not)
form of medicine emerged during the early 20th cen-
men and women, are concurrently both more influen-
tury—what he calls surveillance medicine.15 Within this
tial in the production of medical knowledge (e.g.
configuration of medical discourse, medical scientists
they contribute to knowledge and information on
not only study the bio-physical anatomy and physiol-
the web) and are constructed by as consumers
ogy but also analyse the distribution of disease, illness
deployed by the pharmaceutical, biotechnology and
patients are recruited to monitor their own health
risks and encouraged to maintain their own health.
Conflict of interest: None declared.
Whilst Jewson had argued that the patient as aperson had all but ‘disappeared’ from medical dis-course, within surveillance medicine, the patient—and indeed ‘potential’ patients—reappear with a new
(risk) identity. Responsibility, and increasingly culp-
1 Jewson ND. The disappearance of the sick-man from
ability for health status, lies with the ‘person’ who is
medical cosmology, 1770–1870. Sociology 1976;10:225–44.
impelled to become aware of, and act upon, the
Reprinted in Int J Epidemiol 2009; doi:10.1093.ije/dyp180.
wealth of health information and advice to be found
2 Turner BS. Medical Power and Social Knowledge. London:
not only in the health clinic, but also throughout var-
ious forms of popular media, on supermarket shelves,
3 Strauss R. The nature and status of medical sociology.
Armstrong, however, talks not of a new form of
4 Jewson N. Medical knowledge and the patronage system
in 18th century England. Sociology 1974;8:369–85.
use the language of Marxism) but rather, after
5 Ackerknecht E. Medicine at the Paris Hospital, 1794–1848.
Foucault.7 he uses the language of ‘spatialisation’.
Baltimore: The John Hopkins Press, 1967, p. 22.
But, fundamentally, both Jewson and Armstrong are
6 Armstrong D. Clinical autonomy, individual and collec-
describing shifts in the way medical knowledge is
tive: the problem of changing doctors’ behaviour. Soc Sci
configured and sustained—they describe transforma-
tions in the ways medicine conceives, constructs and
7 Harrison S. The politics of evidence-based medicine in the
describes its objects of study. The moves from bedside
United Kingdom. Policy Poli 1998;26:15–30.
to hospital, from hospital to laboratory; and from the
8 Foucault M. The Birth of the Clinic: An Archaeology of Medical
micro-analyses of bodily components to the analyses
Perception. London: Tavistock, 1976.
of epidemiological data derived from the community,
9 Greenhalgh J, Flynn R, Long AF, Tyson S. Tacit and
are associated with differential technological forms
encoded knowledge in the use of standardised outcome
and materials. The stethoscope, the microscope and
measures in multidisciplinary team decision making: acase study of in-patient neurorehabilitation.
statistical technologies are differentially privileged.
Perhaps today, networked computer systems comprise
10 McDonald R, Waring J, Harrison S, Walshe K, Boaden R.
the dominant technological form; since they impact
Rules and guidelines in clinical practice: a qualitative
not simply on the capacity to process data but also
study in operating theatres of doctors’ and nurses’
influence our ways of thinking and arguably give rise
views. Qual Saf Health Care 2005;14:290–94.
to a new medical cosmology namely, ‘e-scaped med-
11 Nettleton S, Burrows R, Watt I. Regulating medical
bodies? The ‘modernisation’ of the NHS and the disem-
and has ‘escaped’ from the formal institutions of
the medical establishment. Furthermore, knowledge
12 Conrad P. The shifting engines of medicalization. J Health
15 Armstrong D. The rise of surveillance medicine. Sociol
13 Healy D. The latest mania: selling bipolar disorder. PLoS
16 Nettleton S. The emergence of e-scaped medicine?
14 Rose N. Neurochemical selves. Society 2003;41:46–59.
1. a) “Contest Period” begins Tuesday September 3 , 2013 at approximately 12:01am MT and ends on Sunday October 27, 2013 at 11:59pm MT (the “Contest Closing Date”). There are three (3) ways to enter: (i) visit www.rock106.ca and sign up for the ROCK Rewards CLUB, for free by fully completing the sign up information and then redeem 2500 points for an entry into the Contest, to be submit
The Catamaran™ Preferred Drug List (PDL) is a guide identifying preferred medicines within select therapeutic categories. The PDL is an abbreviated drug list which includes the most commonly prescribed Tier 1 and Tier 2 medicines. Tier 1 drugs are listed in lowercase italics and Tier 2 drugs are listed in CAPS. This listing is revised periodical y as new drugs and new prescribing infor